About
With over 20 years of experience in applying Data Science and Artificial Intelligence to…
Activity
-
Welcome Ezequiel Renzulli to BIOMAKERS as our New Chief Strategy Officer! We are thrilled to announce that Ezequiel Renzulli is joining BIOMAKERS as…
Welcome Ezequiel Renzulli to BIOMAKERS as our New Chief Strategy Officer! We are thrilled to announce that Ezequiel Renzulli is joining BIOMAKERS as…
Liked by Iker Huerga
-
I’m delighted to share that AstraZeneca has entered into a license and option agreement with Pinetree Therapeutics, a biotechnology company…
I’m delighted to share that AstraZeneca has entered into a license and option agreement with Pinetree Therapeutics, a biotechnology company…
Liked by Iker Huerga
-
I’m pleased to share some exciting news from Oncology R&D, AstraZeneca. We have entered into a license and option agreement with Pinetree…
I’m pleased to share some exciting news from Oncology R&D, AstraZeneca. We have entered into a license and option agreement with Pinetree…
Liked by Iker Huerga
Experience
Education
Publications
-
Semantically enabling pharmacogenomic data for the realization of personalized medicine
Pharmacogenomics, Future Medicine
Understanding how each individual's genetics and physiology influences pharmaceutical response is crucial to the realization of personalized medicine and the discovery and validation of pharmacogenomic biomarkers is key to its success. However, integration of genotype and phenotype knowledge in medical information systems remains a critical challenge
-
An informatics infrastructure for translating pharmacogenomic knowledge into clinical practice
AMIA Summit on Translational Bioinformatics, conference article
-
Fundamentals of Semantic Web Technologies in Medical Environments: A Case in Breast Cancer Risk Estimation.
Proceedings of the 3rd International Workshop on Semantic Web Applications and Tools for the Life Sciences
Risk estimation of developing breast cancer poses as the first prevention method for early diagnosis. Furthermore, data integration from different departments involved in the process plays a key role. In order to guarantee patient safety, the whole process should be orchestrated and monitored automatically. Support for the solution will be a linked data cloud, composed by all the departments that take part in the process, combined with rule engines.
-
Supporting Clinical Processes with Semantic Web Technologies: A Case in Breast Cancer Treatment
International Journal of Metadata, Semantics and Ontologies (IJMSO), Inderscience
Breast cancer surgery is carried out almost entirely manually and there is an obvious risk of human error due to temporary or occasional lack of staff experience (substitutions, sick leaves and other reasons). Another aspect is that the successful outcome of the process may depend on the personal attitude of administrative staff. In order to guarantee patient safety the whole process should be orchestrated and monitored automatically. Support for the solution will be a service-oriented…
Breast cancer surgery is carried out almost entirely manually and there is an obvious risk of human error due to temporary or occasional lack of staff experience (substitutions, sick leaves and other reasons). Another aspect is that the successful outcome of the process may depend on the personal attitude of administrative staff. In order to guarantee patient safety the whole process should be orchestrated and monitored automatically. Support for the solution will be a service-oriented architecture combined with semantic web techniques to infer knowledge from predefined rules in order to make the process safe.
Patents
-
Probabilistic Modeling to Match Patients to Clinical Trials
Filed US 62/626625
Languages
-
Spanish
Native or bilingual proficiency
-
English
Full professional proficiency
-
Basque
-
More activity by Iker
-
Today marks a significant milestone in the next chapter (or arc) of my career. After retiring from J&J as the Global Head of Oncology R&D in January,…
Today marks a significant milestone in the next chapter (or arc) of my career. After retiring from J&J as the Global Head of Oncology R&D in January,…
Liked by Iker Huerga
-
A few days ago, our Roche leadership team had the exciting opportunity to meet with NVIDIA at their headquarters in Santa Clara. Bringing science…
A few days ago, our Roche leadership team had the exciting opportunity to meet with NVIDIA at their headquarters in Santa Clara. Bringing science…
Liked by Iker Huerga
-
Ben Erez and I just hit an exciting milestone: our Supra Insider podcast reached 1,000 subscribers and over 3,000 downloads. This journey taught us…
Ben Erez and I just hit an exciting milestone: our Supra Insider podcast reached 1,000 subscribers and over 3,000 downloads. This journey taught us…
Liked by Iker Huerga
-
I’m thrilled to have been invited to beautiful #Barcelona by Luciano Di Croce to deliver a seminar at the Centre for Genomic Regulation (CRG). It’s…
I’m thrilled to have been invited to beautiful #Barcelona by Luciano Di Croce to deliver a seminar at the Centre for Genomic Regulation (CRG). It’s…
Liked by Iker Huerga
-
Feeling energised for the future of Patient Safety after convening in person with my Leadership Team in the UK! Our team is laser-focused on getting…
Feeling energised for the future of Patient Safety after convening in person with my Leadership Team in the UK! Our team is laser-focused on getting…
Liked by Iker Huerga
-
I'm looking forward to seeing colleagues from our Oncology Data Science (ODS) team represent AstraZeneca at #ISMB2024 in Montreal next…
I'm looking forward to seeing colleagues from our Oncology Data Science (ODS) team represent AstraZeneca at #ISMB2024 in Montreal next…
Shared by Iker Huerga
-
Having a blast visiting DeepIntent’s EU office and kicking off our summer ‘24 Product and Engineering summit. It’s great to be spending time with our…
Having a blast visiting DeepIntent’s EU office and kicking off our summer ‘24 Product and Engineering summit. It’s great to be spending time with our…
Liked by Iker Huerga
-
The xT CDx is a next-generation sequencing-based assay that is used for the detection of substitutions, insertions, and deletions and microsatellite…
The xT CDx is a next-generation sequencing-based assay that is used for the detection of substitutions, insertions, and deletions and microsatellite…
Liked by Iker Huerga
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Iker Huerga
-
Iker Huerga
Student at Panamerican University
-
iker huerga uceda
Profesional de Petróleo y energía
-
Iker Huerga
Estudiante en Guadalupeko ama
-
Iker Huerga uceda
--
4 others named Iker Huerga are on LinkedIn
See others named Iker Huerga